GBS outbreak: Nadda asks state to work with central agencies, identify trigger points
GBS is a rare disorder where the immune system attacks the peripheral nervous system which carries signals from the brain and spinal cord to the rest of the body, causing muscle weakness and paralysis ...
The American Journal of Managed Care23h
FDA Approves First Subcutaneous Apomorphine Device for Parkinson Disease
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
Rethinking metastatic brain cancer as a central nervous system disease
A Personal View published in The Lancet Oncology challenges the long-standing perception of metastatic brain cancer, calling ...
Hosted on MSN1d
2 Your Health: FDA approves non-opioid pain medication
Every year, thousands of people die from overdosing on opioids in the United States. But a new non-opioid pain medication, ...
New non-opioid drug introduces new class of pain management medication
Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.
Prosthetic limb gains more natural control through hand–brain connection
Researchers are paving the way for the design of bionic limbs that feel natural to users. They demonstrate the connection ...
FDA approves first non-opioid pain medicine in more than 20 years
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
What is Non-Opioid Pain Medication? Journavx Approved by FDA
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
FDA approves new type of non-opioid pain medication, 1st of its kind in more than 20 years
The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...
Psychology Today5d
Opioid Crisis: Grading the Progress of National Initiatives
Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...
Psychology Today5d
Grading the Progress of National Initiatives on the Opioid Crisis
Two leading drug experts set out a road map to reverse the opioid epidemic in 2016. This is how we've progressed since then.
Health and Me on MSN6d
Chemotherapy Can Lead To Nerve Damage Called The Peripheral Neuropathy, Know What It Means
Under this condition, which can result from traumatic injuries, infections, metabolic problems, or could be inherited due to ...